marketcaparena
Search

    TXMD

    TherapeuticsMD, Inc.

    Company overview

    Market capitalization
    $24.19M
    Employees
    1
    Latest publication
    2026-09-29
    About TherapeuticsMD, Inc.

    TherapeuticsMD, Inc. operates as a pharmaceutical royalty company in the United States and internationally. Its products portfolio includes IMVEXXY for the treatment of moderate-to-severe dyspareunia, a symptom of vulvar and vaginal atrophy due to menopause; BIJUVA to treat moderate-to-severe vasomotor symptoms due to menopause in women with a uterus; and ANNOVERA, a ring-shaped contraceptive vaginal system. The company also offers prescription prenatal vitamin products under the BocaGreenMD and vitaMedMD brand names. It has a license agreement with Mayne Pharma Group Limited. The company sells its products through wholesale distributors and retail pharmacy distributors. TherapeuticsMD, Inc. was founded in 2008 and is headquartered in Boca Raton, Florida.

    Company website

    Financial statements

    Income Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ2 20262026-06-30 · USDQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USD
    Total Revenue869,000USD724,000USD893,000USD784,000USD952,000USD393,000USD667,000USD547,000USD
    Selling General Administrative1,577,000USD1,353,000USD2,292,000USD1,518,000USD1,551,000USD1,081,000USD879,000USD1,310,000USD
    General And Administrative Expenses1,577,000USD———————
    Total Operating Expenses1,685,000USD1,122,000USD2,389,000USD1,614,000USD1,647,000USD1,264,000USD986,000USD1,406,000USD
    Operating Income-816,000USD-723,000USD-1,496,000USD-830,000USD-695,000USD-871,000USD-319,000USD-859,000USD
    Total Other Income Expense Net980,000USD826,000USD916,000USD880,000USD1,240,000USD203,000USD402,000USD292,000USD
    Interest Income69,000USD41,000USD———29,000USD——
    Income Before Tax164,000USD103,000USD-580,000USD50,000USD545,000USD-668,000USD83,000USD-567,000USD
    Income Tax Expense0USD8,000USD32,000USD-102,000USD-6,000USD-32,000USD-31,000USD42,000USD
    Discontinued Operations-9,000USD———————
    Net Income155,000USD95,000USD-619,000USD152,000USD551,000USD-653,000USD252,000USD-609,000USD
    Cost Of Revenue—325,000USD906,000USD96,000USD96,000USD133,000USD——
    Gross Profit—399,000USD893,000USD784,000USD952,000USD393,000USD667,000USD547,000USD
    Net Interest Income—41,000USD149,000USD-3,000USD-2,000USD-2,000USD—-3,000USD
    Tax Provision—0USD32,000USD0USD0USD-32,000USD-31,000USD0USD
    Net Income From Continuing Ops—103,000USD-612,000USD50,000USD545,000USD-636,000USD114,000USD-567,000USD
    Ebit—-723,000USD-4,148,000USD53,000USD-319,000USD-783,000USD-1,074,000USD-859,000USD
    Ebitda—-398,000USD-3,242,000USD149,000USD-223,000USD-688,000USD-974,000USD-763,000USD
    Depreciation And Amortization—325,000USD906,000USD96,000USD96,000USD95,000USD100,000USD96,000USD
    Reconciled Depreciation—94,000USD906,000USD96,000USD96,000USD95,000USD100,000USD96,000USD
    Interest Expense——7,000USD3,000USD2,000USD2,000USD—3,000USD
    SourceDisclosureDeterministicFinalLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Income Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USDFY 20212021-12-31 · USDFY 20202020-12-31 · USDFY 20192019-12-31 · USDFY 20182018-12-31 · USD
    Total Revenue3,022,000USD1,761,000USD1,302,000USD69,963,000USD2,573,000USD64,872,000USD49,647,000USD16,099,460USD
    Cost Of Revenue1,193,000USD509,000USD922,000USD1,397,000USD1,402,000USD15,975,000USD6,335,000USD2,737,652USD
    Gross Profit3,022,000USD1,761,000USD1,302,000USD68,566,000USD1,171,000USD48,897,000USD43,312,000USD13,361,808USD
    Selling General Administrative6,852,000USD4,744,000USD18,963,000USD57,903,000USD72,748,000USD76,954,000USD60,494,000USD115,988,954USD
    Total Operating Expenses7,236,000USD6,521,000USD9,825,000USD67,375,000USD80,748,000USD204,438,000USD194,517,000USD143,581,978USD
    Operating Income-4,214,000USD-4,760,000USD-8,523,000USD1,191,000USD-79,577,000USD-155,541,000USD-151,205,000USD-130,220,170USD
    Interest Income142,000USD135,000USD————0USD0USD
    Net Interest Income142,000USD135,000USD—-38,517,000USD-32,917,000USD-28,581,043USD-17,382,215USD-4,677,834USD
    Income Before Tax-653,000USD-2,343,000USD-7,742,000USD1,074,000USD-79,305,000USD-183,524,000USD-176,145,000USD-132,617,160USD
    Income Tax Expense-84,000USD-31,000USD-43,000USD-91,862,000USD33,189,000USD29,178,690USD19,882,321USD2,280,844USD
    Tax Provision0USD-31,000USD-43,000USD290,000USD550,000USD0USD0USD0USD
    Net Income-569,000USD-2,181,000USD-10,278,000USD111,997,000USD-172,415,000USD-183,524,000USD-176,145,000USD-132,617,160USD
    Net Income From Continuing Ops-653,000USD-2,312,000USD42,295,000USD1,074,000USD-172,415,000USD-183,524,137USD-176,144,999USD-132,617,160USD
    Ebit-4,214,000USD-3,492,000USD-8,523,000USD10,663,000USD-71,577,000USD-157,475,000USD-159,619,000USD-127,939,330USD
    Ebitda-3,021,000USD-2,983,000USD-8,084,500USD11,863,000USD-70,841,000USD-153,408,000USD-158,227,000USD-127,645,444USD
    Depreciation And Amortization1,193,000USD509,000USD438,500USD1,200,000USD736,000USD4,067,000USD1,392,000USD293,886USD
    Reconciled Depreciation1,193,000USD509,000USD594,000USD1,193,000USD4,093,000USD4,066,561USD1,391,478USD293,886USD
    Total Other Income Expense Net3,561,000USD2,417,000USD781,000USD-117,000USD272,000USD-27,983,000USD-24,940,000USD-2,396,990USD
    Unclassified Operating Expenses—1,777,000USD-9,138,000USD2,767,000USD————
    Interest Expense—9,500USD—12,273,000USD32,917,000USD28,581,043USD17,382,215USD4,677,834USD
    Research Development———5,512,000USD7,086,000USD10,432,000USD19,792,000USD27,299,138USD
    Selling And Marketing Expenses———1,193,000USD—117,052,000USD114,231,000USD—
    Non Operating Income Net Other————272,000USD597,647USD—2,280,844USD
    Net Income Applicable To Common Shares————-172,415,000USD-183,524,137USD-176,144,999USD-132,617,160USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Balance sheet Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ2 20262026-06-30 · USDQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USD
    Total Assets37,529,000USD37,581,000USD37,656,000USD38,671,000USD38,504,000USD38,236,000USD38,822,000USD39,552,000USD
    Total Current Assets16,121,000USD15,263,000USD14,445,000USD12,169,000USD13,461,000USD12,512,000USD9,925,000USD12,154,000USD
    Other Current Assets3,538,000USD3,633,000USD3,437,000USD1,389,000USD3,649,000USD3,771,000USD1,304,000USD3,784,000USD
    Other Non Current Assets395,000USD———————
    Total Liabilities10,397,000USD———————
    Total Current Liabilities5,003,000USD4,911,000USD4,785,000USD4,945,000USD4,662,000USD4,741,000USD5,166,000USD5,976,000USD
    Other Non Current Liabilities873,000USD———————
    Total Stockholder Equity27,132,000USD26,973,000USD26,876,000USD27,444,000USD27,292,000USD26,740,000USD27,370,000USD27,094,000USD
    Total Equity Including Noncontrolling Interest27,132,000USD———————
    Property Plant Equipment Net4,828,000USD5,062,000USD5,293,000USD5,515,000USD5,732,000USD5,948,000USD6,102,000USD6,302,000USD
    Intangible Assets3,559,000USD3,667,000USD3,761,000USD3,914,000USD4,043,000USD4,138,000USD4,321,000USD4,428,000USD
    Accounts Payable460,000USD15,000USD377,000USD263,000USD350,000USD176,000USD258,000USD234,000USD
    Short Term Debt1,039,000USD——1,072,000USD886,000USD1,010,999USD1,633,000USD1,623,000USD
    Common Stock11,000USD11,000USD11,000USD11,000USD11,000USD11,000USD11,000USD11,000USD
    Retained Earnings-952,141,000USD-952,296,000USD-952,391,000USD-951,772,000USD-951,924,000USD-952,475,000USD-951,822,000USD-952,074,000USD
    Total Liab—10,608,000USD10,780,000USD11,227,000USD11,212,000USD11,496,000USD11,452,000USD12,458,000USD
    Other Current Liab—4,896,000USD4,408,000USD3,610,000USD3,426,000USD3,554,001USD3,275,000USD4,119,000USD
    Capital Stock—11,000USD11,000USD11,000USD11,000USD11,000USD11,000USD11,000USD
    Cash—8,419,000USD7,483,000USD7,115,000USD6,069,000USD5,745,000USD5,059,000USD5,047,000USD
    Cash And Short Term Investments—8,419,000USD7,483,000USD7,115,000USD6,069,000USD5,745,000USD5,059,000USD5,047,000USD
    Net Debt—-3,595,000USD-2,361,000USD-632,000USD535,000USD1,225,999USD2,116,000USD2,353,000USD
    Short Long Term Debt Total—4,824,000USD5,122,000USD6,483,000USD6,604,000USD6,970,999USD7,175,000USD7,400,000USD
    Net Receivables—3,211,000USD3,525,000USD3,665,000USD3,743,000USD2,996,000USD3,562,000USD3,323,000USD
    Property Plant Equipment Gross—5,062,000USD5,293,000USD5,515,000USD5,732,000USD5,948,000USD6,102,000USD6,302,000USD
    Common Stock Shares Outstanding—11,640,000shares11,569,000shares11,574,000shares11,574,000shares11,552,000shares11,532,432shares11,532,000shares
    Non Current Assets Total—22,318,000USD23,211,000USD26,502,000USD25,043,000USD25,724,000USD28,897,000USD27,398,000USD
    Non Current Liabilities Total—5,697,000USD5,995,000USD6,282,000USD6,550,000USD6,755,000USD6,286,000USD6,482,000USD
    Non Current Liabilities Other—873,000USD873,000USD871,000USD832,000USD795,000USD744,000USD705,000USD
    Non Currrent Assets Other—13,589,000USD14,157,000USD2,804,000USD15,268,000USD15,638,000USD2,464,000USD16,668,000USD
    Net Working Capital—10,352,000USD9,660,000USD9,558,000USD8,799,000USD7,771,000USD7,093,000USD6,178,000USD
    Unclassified Non Current Liabilities—4,824,000USD5,122,000USD5,411,000USD5,718,000USD5,960,000USD5,542,000USD5,777,000USD
    Unclassified Equity—979,247,000USD979,245,000USD979,194,000USD979,194,000USD979,193,000USD979,170,000USD979,146,000USD
    Unclassified Non Current Assets———14,269,000USD——16,010,000USD—
    Accumulated Other Comprehensive Income————0USD0USD—0USD
    SourceDisclosureDeterministicFinalLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Balance sheet Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USDFY 20212021-12-31 · USDFY 20202020-12-31 · USDFY 20192019-12-31 · USDFY 20182018-12-31 · USD
    Total Assets37,656,000USD38,822,000USD43,309,000USD90,458,000USD169,472,000USD181,610,000USD265,985,637USD211,983,924USD
    Intangible Assets3,761,000USD4,321,000USD6,098,000USD6,943,000USD7,144,000USD41,445,000USD44,479,519USD24,092,679USD
    Other Current Assets3,437,000USD1,304,000USD4,379,000USD17,284,000USD10,763,000USD7,543,001USD11,329,793USD10,834,693USD
    Total Liab10,780,000USD11,452,000USD14,022,000USD55,315,000USD263,093,000USD305,611,000USD256,784,517USD114,459,803USD
    Total Stockholder Equity26,876,000USD27,370,000USD29,287,000USD35,143,000USD-93,621,000USD-124,001,000USD9,201,120USD97,524,121USD
    Other Current Liab4,408,000USD3,275,000USD5,354,000USD43,287,000USD59,888,000USD35,916,000USD32,322,074USD18,334,948USD
    Common Stock11,000USD11,000USD11,000USD9,000USD9,000USD300,000USD271,177USD240,463USD
    Capital Stock11,000USD11,000USD11,000USD9,000USD430,000USD299,765USD271,177USD240,463USD
    Retained Earnings-952,391,000USD-951,822,000USD-949,641,000USD-939,363,000USD-1,051,360,000USD-878,945,000USD-695,421,279USD-519,276,280USD
    Cash7,483,000USD5,059,000USD4,327,000USD38,067,000USD64,907,000USD80,486,000USD160,829,713USD161,613,077USD
    Cash And Short Term Investments7,483,000USD5,059,000USD4,327,000USD38,067,000USD64,907,000USD80,486,000USD160,829,713USD161,613,077USD
    Total Current Assets14,445,000USD9,925,000USD11,796,000USD55,351,000USD119,468,000USD128,404,000USD208,416,180USD186,779,261USD
    Total Current Liabilities4,785,000USD5,166,000USD6,854,000USD46,839,000USD252,891,000USD59,238,000USD53,004,825USD41,078,789USD
    Net Debt-2,361,000USD2,116,000USD3,678,000USD-29,308,000USD132,786,000USD168,141,000USD44,451,518USD-88,232,063USD
    Short Long Term Debt Total5,122,000USD7,175,000USD8,005,000USD8,759,000USD197,693,000USD248,627,000USD205,281,231USD73,381,014USD
    Net Receivables3,525,000USD3,562,000USD3,090,000USD—36,176,000USD32,381,999USD24,395,958USD11,063,821USD
    Accounts Payable377,000USD258,000USD27,000USD2,162,000USD3,373,000USD21,068,000USD19,181,212USD22,743,841USD
    Property Plant Equipment Net5,293,000USD6,102,000USD6,873,000USD7,658,000USD9,057,000USD11,508,000USD12,616,929USD472,683USD
    Property Plant Equipment Gross5,293,000USD6,102,000USD6,873,000USD10,103,000USD9,433,000USD11,507,924USD12,616,929USD472,683USD
    Common Stock Shares Outstanding11,569,000shares11,532,000shares10,441,000shares9,028,000shares7,960,000shares5,512,971shares4,927,066shares4,500,526shares
    Non Current Assets Total23,211,000USD28,897,000USD31,513,000USD35,107,000USD50,004,000USD53,206,000USD57,569,457USD25,204,663USD
    Non Current Liabilities Total5,995,000USD6,286,000USD7,168,000USD8,476,000USD10,202,000USD246,373,000USD203,779,692USD73,381,014USD
    Non Current Liabilities Other873,000USD744,000USD636,000USD1,107,000USD2,139,000USD8,675,477USD——
    Non Currrent Assets Other14,157,000USD2,464,000USD18,542,000USD20,506,000USD33,803,000USD253,000USD473,009USD639,301USD
    Net Working Capital9,660,000USD7,093,000USD4,942,000USD8,512,000USD-133,423,000USD69,165,773USD155,411,355USD145,700,472USD
    Unclassified Non Current Liabilities5,122,000USD5,542,000USD6,532,000USD7,369,000USD8,060,861USD—9,145,049USD—
    Unclassified Equity979,245,000USD979,170,000USD978,906,000USD974,488,000USD957,300,000USD754,344,235USD705,048,869USD616,873,105USD
    Short Term Debt—1,633,000USD1,473,000USD1,390,000USD189,630,000USD2,254,000USD1,501,539USD—
    Unclassified Non Current Assets—16,010,000USD———-46,015,737USD——
    Other Assets——1USD—253USD46,015,737USD473,009USD639,301USD
    Accumulated Other Comprehensive Income——0USD0USD0USD—-968,824USD-553,630USD
    Current Deferred Revenue———1,011,000USD39,587,000USD-2,253,994USD-1,501,539USD—
    Unclassified Current Liabilities———-1,011,000USD-227,856,000USD———
    Other Liab————2,139USD———
    Short Long Term Debt————188,269,000USD———
    Inventory————7,622,000USD7,993,000USD11,860,716USD3,267,670USD
    Net Tangible Assets————-133,939USD-124,001,551USD-35,278,399USD93,431,442USD
    Long Term Debt—————237,697,531USD194,634,643USD73,381,014USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Cash flow Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USDQ2 20242024-06-30 · USD
    Net Income103,000USD-612,000USD50,000USD545,000USD-636,000USD114,000USD-567,000USD-1,090,000USD
    Depreciation325,000USD906,000USD96,000USD96,000USD95,000USD100,000USD96,000USD180,000USD
    Stock Based Compensation2,000USD51,000USD0USD1,000USD24,000USD24,000USD33,000USD96,000USD
    Other Non Cash Items-6,000USD-486,000USD295,000USD160,000USD252,000USD-784,000USD115,000USD936,000USD
    Change In Working Capital514,000USD560,000USD605,000USD-477,000USD975,000USD563,000USD171,000USD772,000USD
    Total Cash From Operating Activities936,000USD368,000USD1,046,000USD324,000USD686,000USD17,000USD-185,000USD894,000USD
    Capital Expenditures0USD0USD0USD0USD0USD0USD0USD0USD
    Free Cash Flow936,000USD368,000USD1,046,000USD324,000USD686,000USD17,000USD-185,000USD894,000USD
    Change In Cash936,000USD368,000USD1,046,000USD324,000USD686,000USD12,000USD-185,000USD894,000USD
    Begin Period Cash Flow7,483,000USD7,115,000USD6,069,000USD5,745,000USD5,059,000USD5,047,000USD5,232,000USD4,338,000USD
    End Period Cash Flow8,419,000USD7,483,000USD7,115,000USD6,069,000USD5,745,000USD5,059,000USD5,047,000USD5,232,000USD
    Total Cash From Financing Activities—————0USD0USD—
    Issuance Of Capital Stock—————0USD0USD—
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Cash flow Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USDFY 20212021-12-31 · USDFY 20202020-12-31 · USDFY 20192019-12-31 · USDFY 20182018-12-31 · USD
    Net Income-653,000USD-2,312,000USD-7,699,000USD1,074,000USD-79,305,000USD-183,524,000USD-176,145,000USD-132,617,160USD
    Depreciation1,193,000USD509,000USD922,000USD1,193,000USD736,000USD4,067,000USD1,391,478USD293,886USD
    Stock Based Compensation75,000USD264,000USD1,271,000USD11,572,000USD18,125,000USD10,679,000USD10,682,000USD8,661,967USD
    Other Non Cash Items221,000USD875,000USD-23,918,000USD-13,831,000USD-73,833,000USD12,648,000USD1,918,620USD269,859USD
    Change In Working Capital1,663,000USD1,660,000USD-17,446,000USD-4,086,000USD4,591,000USD-3,341,000USD-14,000,290USD16,363,645USD
    Total Cash From Operating Activities2,424,000USD732,000USD-48,141,000USD-4,078,000USD-147,811,000USD-159,471,000USD-165,697,595USD-106,811,781USD
    Capital Expenditures0USD0USD-48,141,000USD-355,000USD-34,000USD-1,598,000USD-23,892,274USD-21,322,447USD
    Free Cash Flow2,424,000USD732,000USD-48,141,000USD-4,433,000USD-147,845,000USD-161,069,000USD-189,589,869USD-128,134,228USD
    Change In Cash2,424,000USD732,000USD-44,990,000USD-15,805,000USD-15,578,784USD-80,344,000USD-783,364USD34,477,449USD
    Begin Period Cash Flow5,059,000USD4,327,000USD49,317,000USD65,122,000USD80,485,784USD160,830,000USD161,613,077USD127,135,628USD
    End Period Cash Flow7,483,000USD5,059,000USD4,327,000USD49,317,000USD64,907,000USD80,486,000USD160,829,713USD161,613,077USD
    Total Cash From Financing Activities—0USD3,151,000USD-235,206,000USD134,670,000USD80,725,000USD188,826,925USD162,787,087USD
    Issuance Of Capital Stock—0USD22,847,000USD24,152,000USD184,115,000USD31,702,635USD77,031,258USD89,907,797USD
    Investments——223,760,000USD223,479,000USD-2,223,000USD-1,597,907USD-23,912,694USD-21,497,857USD
    Net Borrowings——0USD-219,432,000USD-50,000,000USD48,750,000USD118,339,281USD71,213,082USD
    Sale Purchase Of Stock——0USD-38,657,000USD184,437,000USD31,974,313USD77,139,910USD91,574,005USD
    Other Cashflows From Financing Activities——3,151,000USD-1,269,000USD-4,796,000USD-978,000USD-6,543,000USD-2,120,710USD
    Unclassified Operating Cash Flow——-1,271,000USD—-18,125,000USD—10,455,597USD—
    Change To Account Receivables———4,277,000USD-4,327,000USD-8,224,000USD-13,639,575USD-6,951,041USD
    Change To Inventory———588,000USD-711,000USD-3,337,000USD-8,593,046USD-1,782,312USD
    Total Cashflows From Investing Activities———223,479,000USD-2,223,000USD-1,598,000USD-23,912,694USD-21,497,857USD
    Other Cashflows From Investing Activities———223,834,000USD-2,189,000USD-1,391,000USD-20,420USD-175,410USD
    Unclassified Investing Cash Flow———-223,479,000USD2,223,000USD2,988,907USD23,912,694USD21,497,857USD
    Unclassified Financing Cash Flow———24,152,000USD5,029,000USD——2,120,710USD
    Change To Liabilities————-750,000USD4,791,062USD-3,562,629USD27,754,188USD
    Cash And Cash Equivalents Changes————-15,364,000USD-80,343,929USD—34,477,449USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Operating metrics

    No operating metrics are currently published for this company.

    Revenue breakdown

    PeriodDimensionBusiness / regionRevenueCurrencySource
    Q1 2026Quarterly · 2026-03-31GeographyInternational480,000USD0001213900-26-055081
    Q1 2026Quarterly · 2026-03-31GeographyUnited States244,000USD0001213900-26-055081
    Q4 2025Quarterly · 2025-12-31GeographyInternational365,000USDLegacy provider
    Q4 2025Quarterly · 2025-12-31GeographyUnited States528,000USDLegacy provider
    FY 2025Yearly · 2025-12-31GeographyInternational1,230,000USD0001213900-26-036515
    FY 2025Yearly · 2025-12-31GeographyUnited States1,792,000USD0001213900-26-036515
    Q3 2025Quarterly · 2025-09-30GeographyInternational336,000USD0001213900-25-109381
    Q3 2025Quarterly · 2025-09-30GeographyUnited States448,000USD0001213900-25-109381
    Q2 2025Quarterly · 2025-06-30GeographyInternational310,000USD0001213900-25-075003
    Q2 2025Quarterly · 2025-06-30GeographyUnited States642,000USD0001213900-25-075003
    Q1 2025Quarterly · 2025-03-31GeographyInternational219,000USD0001213900-26-055081
    Q1 2025Quarterly · 2025-03-31GeographyUnited States174,000USD0001213900-26-055081
    Q4 2024Quarterly · 2024-12-31GeographyInternational235,000USDLegacy provider
    Q4 2024Quarterly · 2024-12-31GeographyUnited States432,000USDLegacy provider
    FY 2024Yearly · 2024-12-31GeographyInternational638,000USD0001213900-26-036515
    FY 2024Yearly · 2024-12-31GeographyUnited States1,123,000USD0001213900-26-036515
    Q3 2024Quarterly · 2024-09-30GeographyInternational163,000USD0001213900-25-109381
    Q3 2024Quarterly · 2024-09-30GeographyUnited States384,000USD0001213900-25-109381
    Q2 2024Quarterly · 2024-06-30GeographyInternational130,000USD0001213900-25-075003
    Q2 2024Quarterly · 2024-06-30GeographyUnited States104,000USD0001213900-25-075003
    FY 2023Yearly · 2023-12-31GeographyInternational299,000USD0001013762-25-003442
    FY 2023Yearly · 2023-12-31GeographyUnited States1,003,000USD0001013762-25-003442
    Q3 2022Quarterly · 2022-09-30ProductAnnovera10,415,000USD0001564590-22-037666
    Q3 2022Quarterly · 2022-09-30ProductBijuva2,663,000USD0001564590-22-037666
    Q3 2022Quarterly · 2022-09-30ProductImvexxy6,947,000USD0001564590-22-037666
    Q3 2022Quarterly · 2022-09-30ProductPrescription Vitamins892,000USD0001564590-22-037666
    Q2 2022Quarterly · 2022-06-30ProductLicense And Service65,000USD0001564590-22-029490
    Q2 2022Quarterly · 2022-06-30ProductProduct28,496,000USD0001564590-22-029490
    Q1 2022Quarterly · 2022-03-31ProductLicense And Service419,000USD0001564590-22-020440
    Q1 2022Quarterly · 2022-03-31ProductProduct18,914,000USD0001564590-22-020440
    Q3 2021Quarterly · 2021-09-30ProductAnnovera11,807,000USD0001564590-22-037666
    Q3 2021Quarterly · 2021-09-30ProductBijuva3,298,000USD0001564590-22-037666
    Q3 2021Quarterly · 2021-09-30ProductImvexxy8,016,000USD0001564590-22-037666
    Q3 2021Quarterly · 2021-09-30ProductLicense And Service950,000USD0001564590-22-037666
    Q3 2021Quarterly · 2021-09-30ProductPrescription Vitamins1,335,000USD0001564590-22-037666
    Q2 2021Quarterly · 2021-06-30ProductAnnovera9,555,000USD0001564590-21-040907
    Q2 2021Quarterly · 2021-06-30ProductBijuva2,156,000USD0001564590-21-040907
    Q2 2021Quarterly · 2021-06-30ProductImvexxy9,838,000USD0001564590-21-040907
    Q2 2021Quarterly · 2021-06-30ProductPrescription Vitamins1,452,000USD0001564590-21-040907
    Q1 2021Quarterly · 2021-03-31ProductLicense And Service234,000USD0001564590-22-020440
    Q1 2021Quarterly · 2021-03-31ProductProduct19,632,000USD0001564590-22-020440
    FY 2020Yearly · 2020-12-31ProductAnnovera19,611,286USD0001387131-21-003140
    FY 2020Yearly · 2020-12-31ProductBijuva6,353,963USD0001387131-21-003140
    FY 2020Yearly · 2020-12-31ProductImvexxy27,139,387USD0001387131-21-003140
    FY 2020Yearly · 2020-12-31ProductLicense2,000,000USD0001387131-21-003140
    FY 2020Yearly · 2020-12-31ProductPrescription Vitamins9,767,644USD0001387131-21-003140
    Q3 2020Quarterly · 2020-09-30ProductAnnovera6,418,990USD0001387131-20-009695
    Q3 2020Quarterly · 2020-09-30ProductBijuva1,646,320USD0001387131-20-009695
    Q3 2020Quarterly · 2020-09-30ProductImvexxy6,841,592USD0001387131-20-009695
    Q3 2020Quarterly · 2020-09-30ProductLicense2,000,000USD0001387131-20-009695
    Q3 2020Quarterly · 2020-09-30ProductPrescription Vitamins2,435,903USD0001387131-20-009695
    Q2 2020Quarterly · 2020-06-30ProductAnnovera1,835,000USD0001564590-21-040907
    Q2 2020Quarterly · 2020-06-30ProductBijuva1,352,000USD0001564590-21-040907
    Q2 2020Quarterly · 2020-06-30ProductImvexxy5,086,000USD0001564590-21-040907
    Q2 2020Quarterly · 2020-06-30ProductPrescription Vitamins2,428,000USD0001564590-21-040907
    FY 2019Yearly · 2019-12-31ProductAnnovera6,166,556USD0001387131-21-003140
    FY 2019Yearly · 2019-12-31ProductBijuva1,836,443USD0001387131-21-003140
    FY 2019Yearly · 2019-12-31ProductImvexxy16,252,045USD0001387131-21-003140
    FY 2019Yearly · 2019-12-31ProductLicense15,506,400USD0001387131-21-003140
    FY 2019Yearly · 2019-12-31ProductPrescription Vitamins9,885,493USD0001387131-21-003140
    FY 2018Yearly · 2018-12-31ProductImvexxy1,058,201USD0001387131-21-003140
    FY 2018Yearly · 2018-12-31ProductPrescription Vitamins15,041,259USD0001387131-21-003140
    FY 2017Yearly · 2017-12-31ProductOtc Products32,882USD0001387131-20-002086
    FY 2017Yearly · 2017-12-31ProductPrescription Vitamins16,744,831USD0001387131-20-002086
    FY 2016Yearly · 2016-12-31ProductOtc Products501,466USD0001387131-19-001471
    FY 2016Yearly · 2016-12-31ProductPrescription Vitamins18,854,984USD0001387131-19-001471

    Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.